Study guide

27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management

Philippine Radiologic Technologists Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Subject 1, Chapter 1: Physics of Radiology & X-Ray Production

1.1 Atomic Structure, Electromagnetic Spectrum & X-Ray Production Mechanisms 1.2 X-Ray Tube Components, Target Interactions & Emission Spectrum 1.3 Photon Interactions with Matter: Photoelectric, Compton, Coherent & Pair Production

2 Subject 1, Chapter 2: Radiographic Equipment & Circuitry

2.1 High-Voltage Generators, Transformers & Rectification Circuits 2.2 Automatic Exposure Control (AEC), Beam Restriction & Quality Control 2.3 Tube Rating Charts, Extending Tube Life, Mechanical Malfunction & Preventive Maintenance

3 Subject 1, Chapter 3: Radiobiology & Cellular Response

3.1 Radiation Interaction with Tissue, Direct/Indirect Action & LET/RBE 3.2 Law of Bergonie & Tribondeau, Deterministic vs. Stochastic Effects 3.3 Dose-Response Relationships, Embryo and Fetal Effects & Acute Radiation Syndrome

4 Subject 1, Chapter 4: Radiation Protection & Dose Limits

4.1 ALARA Principles, Structural Shielding & Dose Limits 4.2 Personnel Dosimetry & Patient Dose Reduction Techniques 4.3 Dose Calculation Problems: Time, Distance, Shielding & Structural Barrier Design

5 Subject 1, Chapter 5: Imaging Informatics & Quality Assurance

5.1 PACS Architecture, DICOM Standards & HL7 Integration 5.2 Quality Assurance & Quality Control Protocols in Diagnostic Radiography 5.3 Radiology Workflow, RIS/HIS Integration, Teleradiology & Informatics Quality Assurance

6 Subject 2, Chapter 6: Film-Screen Radiography & Sensitometry

6.1 Film Emulsion, Latent Image Formation & Darkroom Chemistry 6.2 Sensitometric Curve (H&D Curve), Film Speed & Contrast Characteristics 6.3 Radiographic Film Analysis: Processing Faults, Handling Artifacts & Corrective Measures

7 Subject 2, Chapter 7: Technical Factors & Radiographic Quality

7.1 Density/Brightness, Contrast, Spatial Resolution & Distortion Controls 7.2 Exposure Math: Inverse Square Law, 15% Rule & Grid Conversion Factors 7.3 Technique Compensation: Age, Pathology, Cast and Orthopaedic Devices, Screen Speed & Beam Restriction

8 Subject 2, Chapter 8: Computed Radiography (CR)

8.1 Photostimulable Phosphor (PSP) Plates & CR Reader Mechanics 8.2 Image Processing, CR Artifacts & Erasure Protocols

9 Subject 2, Chapter 9: Digital Radiography (DR)

9.1 Flat-Panel Detectors: Direct vs. Indirect Conversion & TFT Arrays 9.2 Detective Quantum Efficiency (DQE), Modulation Transfer Function (MTF) & Dynamic Range

10 Subject 2, Chapter 10: Exposure Indicators & Image Evaluation

10.1 Exposure Indicators (S-Number, EI, DI), Windowing & Look-Up Tables (LUT) 10.2 Image Critique Checklist, Artifact Identification & Quality Control Standards 10.3 Image Display & Hard-Copy Output: Monitor Classification, DICOM GSDF, Dry vs Wet Laser Imaging

11 Subject 3, Chapter 11: Chest, Abdomen & Routine Positioning Concepts

11.1 Anatomical Terminology, Body Planes & Chest Radiography (PA, Lateral, Decubitus) 11.2 Abdominal Radiography: Acute Abdomen Series & Erect/Supine Protocols 11.3 Radiologic Surface Anatomy, Body Habitus & Sectional Body Cuts

12 Subject 3, Chapter 12: Upper & Lower Extremities & Girdles

12.1 Upper Limb & Shoulder Girdle Positioning (Hand, Wrist, Forearm, Elbow, Humerus, Shoulder) 12.2 Lower Limb & Pelvic Girdle Positioning (Foot, Ankle, Leg, Knee, Femur, Pelvis, Hip)

13 Subject 3, Chapter 13: Spine & Bony Thorax

13.1 Cervical, Thoracic & Lumbar Spine Radiography & Trauma Adaptations 13.2 Sacrum, Coccyx, Sacroiliac Joints & Bony Thorax (Ribs & Sternum)

14 Subject 3, Chapter 14: Cranium, Facial Bones & Paranasal Sinuses

14.1 Skull Positioning: Towne, Caldwell, Lateral & SMV Projections 14.2 Facial Bones, Orbits, Zygomatic Arches & Paranasal Sinuses

15 Subject 3, Chapter 15: Contrast Media Studies & Special Procedures

15.1 Gastrointestinal Contrast Procedures (Esophagram, UGI, Small Bowel, Barium Enema) 15.2 Genitourinary, Biliary & Special Fluoroscopic Studies (IVU, Cystography, ERCP, Myelography) 15.3 Reproductive System Studies: Hysterosalpingography, Pelvimetry & Male Reproductive Procedures 15.4 Nasopharyngography, Sialography & Fistulography / Sinus Tract Visualization

16 Subject 4, Chapter 16: Human Anatomy, Physiology & Pathology Integration

16.1 Body System Anatomy & Systemic Physiology Overview for Radiographers 16.2 Radiologic Pathology: Image Manifestations of Neoplastic, Inflammatory & Traumatic Conditions

17 Subject 4, Chapter 17: Patient Assessment, Communication & Informed Consent

17.1 Professional Communication, History Taking & Patient Rights 17.2 Informed Consent, Medical Documentation & Patient Transfer Safety

18 Subject 4, Chapter 18: Infection Control & Vital Signs Monitoring

18.1 Standard Precautions, Asepsis, Sterilization & Isolation Protocols 18.2 Measurement & Assessment of Vital Signs (BP, Pulse, Respiration, Temperature)

19 Subject 4, Chapter 19: Emergency Care & Aseptic Venipuncture

19.1 Basic Life Support (BLS), CPR Concepts & Emergency Response in Radiology 19.2 Aseptic Venipuncture Technique, IV Maintenance & Extravasation Care

20 Subject 4, Chapter 20: Professional Ethics, Jurisprudence & RA 7431

20.1 Republic Act No. 7431 (Radiologic Technology Act of 1992) & Board Rules 20.2 Code of Professional Ethics, Legal Liabilities, Malpractice & Negligence 20.3 Bioethical Principles in Practice, Professional Virtues & Interprofessional Relationships

21 Subject 5, Chapter 21: Diagnostic Ultrasonography

21.1 Ultrasound Physics, Transducer Construction & Doppler Principles 21.2 Acoustic Artifacts, Clinical Applications & Safety (TI/MI) 21.3 Clinical Ultrasound Examinations: Indications, Patient Preparation, Scanning Protocols & Transducer Selection

22 Subject 5, Chapter 22: Computed Tomography (CT)

22.1 CT Physics, Gantry Components, Detectors & Helical/Multislice Acquisition 22.2 Hounsfield Units, Windowing, CT Artifacts & Radiation Dose (CTDI/DLP)

23 Subject 5, Chapter 23: Magnetic Resonance Imaging (MRI)

23.1 MRI Physics, Nuclear Spin, T1/T2 Relaxation & Pulse Sequences 23.2 MRI Safety (Zones I-IV, SAR, Metallic Implants) & Common Artifacts 23.3 MRI Examination Protocols, Patient Preparation, Gadolinium Contrast & Sectional MRI Anatomy

24 Subject 5, Chapter 24: Interventional Radiology & Vascular Imaging

24.1 Vascular Access, Seldinger Technique & Digital Subtraction Angiography (DSA) 24.2 Interventional Procedures (Embolization, Angioplasty, Stenting) & C-Arm Radiation Safety 24.3 Interventional Patient Management: Contrast Selection, Pre-Procedure Workup & Post-Procedure Care

25 Subject 5, Chapter 25: Contrast Media Pharmacology & Adverse Reactions

25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration 25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols 25.3 General Pharmacologic Principles: Pharmacokinetics, Pharmacodynamics, Drug Categories & the Rights of Drug Safety

26 Subject 5, Chapter 26: Nuclear Medicine & Molecular Imaging

26.1 Radioisotopes, Radiopharmaceuticals & Gamma Camera / SPECT Operation 26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety

27 Subject 5, Chapter 27: Radiation Therapy & Radiation Oncology

27.1 Principles of Radiation Oncology, Linear Accelerators & Treatment Planning 27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management 27.3 Isodose Planning, Treatment Delivery Methods & Radiobiologic Principles in Radiation Therapy

28 Mammography & Dental Radiography

28.1 Mammography: Equipment, CC and MLO Positioning, Compression & Breast Pathology 28.2 Dental Radiography: Paralleling and Bisecting Techniques, Bitewing, Occlusal, Panoramic & Cephalometric

29 Medical Terminology for Radiologic Technology

29.1 Medical Word Building: Root Words, Combining Forms, Prefixes & Suffixes 29.2 Medical Terms in General Medicine, Abbreviations, Symbols & Critiquing Requests and Reports

30 Radiology Administration, Organization & Leadership

30.1 Organizational Structure, Staffing & Licensing Requirements of a Radiology Facility 30.2 Radiology Department Management: Job Descriptions, Duties, Leadership Styles & Entrepreneurial Skills

27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management

Key Takeaways Explain This Topic AI

Teletherapy delivers megavoltage radiation from a remote distance (80–100 cm), featuring skin sparing where maximum dose occurs below the skin surface.

Cobalt-60 teletherapy units emit characteristic gamma photons at 1.17 MeV and 1.33 MeV (average 1.25 MeV) with a 5.26-year half-life.

Brachytherapy places sealed radioactive sources directly inside or adjacent to tumors, utilizing high local doses with rapid Inverse Square Law falloff.

Common brachytherapy isotopes include Ir-192 for HDR remote afterloading, I-125 for permanent prostate seeds, and Cs-137 for LDR cervical applicators.

Rigid patient immobilization (thermoplastic masks, vacuum cushions) ensures setup accuracy within < 2 mm, while acute skin reactions are managed with gentle lukewarm water washing and avoiding perfumed irritants.

Last updated: August 2026

  • 27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management
  • 1. External Beam Radiation Therapy (Teletherapy)

External beam radiation therapy, or teletherapy , involves delivering ionizing radiation from a source located at a distance (typically 80 cm to 100 cm Source-to-Axis Distance [SAD] or Source-to-Surface Distance [SSD]) from the patient's body.

Primary Teletherapy Energy Sources

Megavoltage Linear Accelerators (4 MV to 18 MV Photons):

Modern standard of care for teletherapy. High energy photon beams exhibit a pronounced skin-sparing effect , where the depth of maximum dose ( d max d_{\text{max}} d max ​ ) occurs below the skin surface ( d max ≈ 1.5 cm d_{\text{max}} \approx 1.5\text{ cm} d max ​ ≈ 1.5 cm for 6 MV, 3.0 cm 3.0\text{ cm} 3.0 cm for 18 MV). High MV photon energies provide deep tissue penetration with low surface doses, ideal for deep-seated pelvic, thoracic, and abdominal malignancies.

Cobalt-60 Teletherapy Units:

Historical teletherapy modality utilizing a sealed radioactive source of Cobalt-60 ( 60 Co ^{60}\text{Co} 60 Co ).

Radioactive Decay & Energies: 60 Co ^{60}\text{Co} 60 Co undergoes beta decay into excited Nickel-60 ( 60 Ni ^{60}\text{Ni} 60 Ni ), which immediately emits two characteristic gamma-ray photons with energies of 1.17 MeV and 1.33 MeV (average energy 1.25 MeV ).

Half-Life: Radioactive half-life ( t 1 / 2 t_{1/2} t 1/2 ​ ) of 5.26 years , requiring source replacement or decay corrections of roughly 1% per month.

Physical Limitations: Physical source size (typically 1.5 to 2.0 cm diameter) produces a larger geometric penumbra (fuzzy field edge) compared to the small focal spot of a Linac.

2. Brachytherapy (Internal Sealed Source Therapy)

Brachytherapy ("short-distance therapy") involves placing encapsulated radioactive sources directly inside or immediately adjacent to the tumor volume. Because dose decreases rapidly according to the Inverse Square Law ( I ∝ 1 / r 2 I \propto 1/r^2 I ∝ 1/ r 2 ), brachytherapy delivers an extremely high radiation dose to the tumor while rapidly sparing surrounding normal tissues.

Dose Rate Classifications

Low Dose Rate (LDR): Delivers dose at 0.4 to 2.0 Gy per hour. Requires continuous inpatient hospital stays lasting 24 to 72 hours with permanent or removable source implants.

High Dose Rate (HDR): Delivers dose at rates exceeding 12 Gy per hour (> 0.2 Gy/min). Uses a computer-controlled remote afterloader system that drives a high-activity source through specialized catheters for several minutes per fraction on an outpatient basis.

Radioisotopes Utilized in Brachytherapy

Iodine-125 ( 125 I ^{125}\text{I} 125 I ): Half-life of 59.4 days; emits low-energy X-rays (27–35 keV). Widely used as permanent interstitial seed implants for early-stage prostate carcinoma.

Iridium-192 ( 192 Ir ^{192}\text{Ir} 192 Ir ): Half-life of 73.8 days; emits average gamma energy of 0.38 MeV. High specific activity makes it the primary radionuclide in modern HDR remote afterloading systems for gynecological, breast, and head and neck cancers.

Cesium-137 ( 137 Cs ^{137}\text{Cs} 137 Cs ): Half-life of 30.0 years; emits 0.662 MeV gamma rays. Historically used in LDR manual or remote afterloading for cervical and uterine cancers (Fletcher-Suit applicators).

Gold-198 ( 198 Au ^{198}\text{Au} 198 Au ): Half-life of 2.7 days; emits 0.412 MeV gamma rays. Used for permanent interstitial implants in localized head and neck tumors.

Anatomic Placement Modalities

Interstitial Brachytherapy: Radioactive seeds or needles are inserted directly into the tumor tissue matrix (e.g., prostate seeds, breast interstitial templates).

Intracavitary Brachytherapy: Radioactive sources are positioned inside body cavities adjacent to the tumor using specialized applicators, such as tandem and ovoids or tandem and ring for cervical carcinoma.

Surface Mold (Epicutaneous) Brachytherapy: Sources are arranged on custom-fit plastic molds applied directly to cutaneous or mucosal surfaces (e.g., skin or hard palate lesions).

3. Teletherapy vs. Brachytherapy Comparison Table

  • Property / Feature External Beam Teletherapy Brachytherapy (Internal)
  • Source Location Remote distance (80–100 cm SSD/SAD) Contact or inside tissue (< 1–5 cm distance)

Primary Energy Range Megavoltage photons (4–18 MV) or electrons (4–22 MeV) Low to medium energy gamma/X-rays (27 keV to 0.66 MeV)

Dose Rate & Falloff Relatively uniform beam depth dose profile Rapid dose falloff governed by Inverse Square Law

Common Radioisotopes Cobalt-60 (historical); Linac X-rays Ir-192, I-125, Cs-137, Au-198

Skin Sparing & Penumbra High skin sparing with MV photons; sharp beam edge High local surface dose; no remote beam penumbra

Clinical Application Broad fields; deep organs, regional lymph nodes Highly localized tumors; prostate, cervix, breast

4. Patient Immobilization & Positioning Systems

Precise patient positioning and rigid immobilization are imperative to ensure setup reproducibility within < 2 mm tolerance throughout a multi-week course of radiation therapy.

Immobilization Devices

Thermoplastic Masks: Custom-molded rigid plastic mesh softened in a warm water bath ( 65 − 70 ∘ C 65-70^\circ\text{C} 65 − 7 0 ∘ C ) and contoured precisely over the patient's face, head, neck, or shoulders. Used for brain and head/neck radiation therapy.

Vacuum Cushions (Vac-Lok Systems): Rigid airtight bags filled with polystyrene beads. When positioned under the patient and evacuated with a vacuum pump, the cushion forms a custom, rigid mold supporting the thorax, abdomen, pelvis, or extremities.

Headrests & Knee Fixators: Standardized foam head cushions (e.g., Silverman headrests A-F) and elevated knee bridges to maintain reproducible spinal curvature and pelvic tilt.

Laser Alignment Systems: Three-dimensional room lasers (sagittal, bilateral lateral, and overhead ceiling lasers) align with permanent patient skin tattoos or reference marks establishing the treatment isocenter.

5. Radiation Toxicity & Patient Side Effect Management

Radiation side effects are categorized based on onset timing and underlying cellular pathogenesis into acute toxicities and chronic (late) toxicities .

Acute Side Effects (Occur during or within 90 days of RT)

Caused by rapid radiation-induced cell death in rapidly proliferating stem cell populations (epithelium, mucosal linings, bone marrow):

Erythema: Radiation dermatitis starting around 20–30 Gy due to cutaneous hyperemia and capillary dilation.

Dry Desquamation: Skin flaking, pruritus, and dryness caused by depletion of basal layer epidermal stem cells.

Moist Desquamation: Severe skin peeling, weeping, and exposure of the raw dermal layer occurring in skin folds (groin, axilla, inframammary fold) at doses > 40–50 Gy when basal stem cells are completely depleted.

Mucositis / Stomatitis: Painful mucosal inflammation, ulceration, and dysphagia resulting from mucosal epithelial sloughing in head and neck RT.

Alopecia: Hair loss localized exclusively to the irradiated treatment field; temporary at doses < 30 Gy, permanent at doses > 45–50 Gy.

Fatigue: The single most common universal systemic side effect of radiation therapy, caused by accumulation of cellular debris and cytokine release.

Chronic / Late Side Effects (Occur months to years post RT)

Caused by microvascular damage (endothelial proliferation, ischemia) and irreversible parenchymal replacement by dense connective tissue:

Fibrosis: Progressive tissue induration, joint stiffness, and loss of organ elasticity.

Tissue Necrosis: Osteoradionecrosis (especially of the mandible following dental extraction in head/neck fields) and soft tissue necrosis.

Secondary Malignancy: Radiation-induced secondary neoplasms (e.g., sarcomas or carcinomas) developing in irradiated tissue margins 10 to 30 years post-exposure.

6. Side Effect Classification & Radiation Nursing Care Table

Anatomic Site / Toxicity Acute Manifestations Late / Chronic Manifestations Radiation Nursing & Radiologic Tech Care Guidelines

Skin (Dermatitis) Erythema, dry desquamation, moist desquamation Fibrosis, telangiectasia, skin atrophy, hyperpigmentation Wash gently with lukewarm water & mild non-perfumed soap; avoid scratching, rubbing, adhesive tape, direct sunlight, heating pads, or shaving; apply prescribed hydrophilic lotions (e.g., Aquaphor) only.

Oral Cavity / Mucosa Stomatitis, mucositis, xerostomia (dry mouth), dysgeusia Severe permanent xerostomia, dental caries, osteoradionecrosis Maintain rigorous oral hygiene with soft toothbrush; rinse with normal saline/bicarbonate solution; avoid alcohol/tobacco/spicy foods; fluoride trays for dental preservation.

Gastrointestinal Nausea, vomiting, diarrhea, proctitis, tenesmus Intestinal strictures, chronic bowel obstruction, radiation enteritis Low-residue, low-fat diet; maintain adequate hydration; administer antiemetics or antidiarrheal medications as prescribed.

Systemic (General) Fatigue, lethargy, localized alopecia Secondary radio-induced malignancies Reassure patient that fatigue is expected; encourage balance of light exercise and rest; stress that alopecia is strictly field-localized.